| 5UM Stock | | | EUR 0.58 0.01 1.75% |
Director
Ms. Peng Jiahong is Chief Executive Officer, Executive Vice Chairman of the Board, Chief Financial Officer of the company. She is primarily responsible for financial planning and management, risk management, finance management, human resources and related administrative matters. Ms. Peng was appointed as our Director on December 22, 2014 and was redesignated as our executive Director on March 6, 2015. Ms. Peng has over 20 years working experience in financial services and financial management, including nine years in healthcare finance services. Before joining our Group, Ms. Peng worked as the manager of the finance department from August 1993 to August 2006 in CNTIC and she was mainly responsible for management of financing, fund risk, budgeting and financial reports preparation. Ms. Peng joined our Group in August 2006 as a deputy general manager of the finance department of CU Leasing. She was then promoted to become the general manager of the finance department of CU Leasing in September 2008. She was the chief financial officer and the deputy general manager of CU Leasing and our Company since December 2009 and July 2012 respectively. She was appointed as a director of CU Leasing and our Director in December 2014 respectively since 2018.
| Age | 52 |
| Tenure | 7 years |
| Phone | 86 10 6899 1455 |
| Web | https://www.umcare.cn |
Peng was acting as a director, the chief financial officer and the deputy general manager of CU Leasing since its incorporation in December 2014. On March 6, 2015, Ms. Peng was appointed as the Chief Financial Officer, the deputy general manager and redesignated as an executive Director of Universal Medical.
Genertec Universal Management Efficiency
The company has return on total asset
(ROA) of
0.0283 % which means that it generated a profit of $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1169 %, meaning that it generated $0.1169 on every $100 dollars invested by stockholders. Genertec Universal's management efficiency ratios could be used to measure how well Genertec Universal manages its routine affairs as well as how well it operates its assets and liabilities.
Genertec Universal Medical has accumulated 28.65
B in total debt with debt to equity ratio
(D/E) of 321.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genertec Universal has a current ratio of 3.29, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Genertec Universal until it has trouble settling it off, either with new capital or with free cash flow. So, Genertec Universal's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genertec Universal sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genertec to invest in growth at high rates of return. When we think about Genertec Universal's use of debt, we should always consider it together with cash and equity.
Genertec Universal Medical Group Company Limited provides integrated healthcare services with integration of capital, technology, equipment, specialists, management, and training resources to hospital customers in Mainland China and Hong Kong. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China. GENERTEC UNIVER operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 705 people. Genertec Universal Medical (5UM) is traded on Frankfurt Exchange in Germany and employs 18,077 people.
Management Performance
Genertec Universal Leadership Team
Elected by the shareholders, the Genertec Universal's board of directors comprises two types of representatives: Genertec Universal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genertec. The board's role is to monitor Genertec Universal's management team and ensure that shareholders' interests are well served. Genertec Universal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genertec Universal's outside directors are responsible for providing unbiased perspectives on the board's policies.
Genertec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genertec Universal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Genertec Stock
Genertec Universal financial ratios help investors to determine whether Genertec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genertec with respect to the benefits of owning Genertec Universal security.